Delivery Order SPE2DB24D1205-SPE2DB25FDAVE
- Not listed
- The Defense Logistics Agency awarded a $1,064.58 delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count supply) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $1,349.67 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count units). This firm fixed-price contract, with a completion date of September 9, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,599.60 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count). The contract, awarded on September 19, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and represents a competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a firm fixed price ceiling value of $5,752.28. The award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive delivery order, which carries no set-aside designation, represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,916.54 to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,158.80 for Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules in a 90-count package, with a ceiling value of $2,399.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $2,710.84 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on July 24, 2025, with completion scheduled for July 25, 2025. This is a firm fixed-price contract with no set-aside designation, awarded through open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,599.84 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,533.09 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on August 7, 2025, with completion targeted for August 8, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAVEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,414.63 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) on September 23, 2025, with completion scheduled for September 24, 2025. This competitive award, utilizing firm fixed-price pricing with no set-aside designation, represents a child order under AmerisourceBergen's significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's critical role as a pharmaceutical prime vendor for federal medical procurement, supplying essential medications to support military and veteran healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, the company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains under its comprehensive DLA prime vendor contract. The Esomeprazole supply fulfills immediate medication needs within the Defense Health Agency's pharmaceutical supply chain, reflecting the company's demonstrated capability to meet federal healthcare procurement requirements through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 9/23/25 |